Active	Status	Sponsor type	Region	Phase	Filter
1 Active 15 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
serlopitant (JTS 661) / Vyne Therap
2017-003250-16: A Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Chronic Cough with No Apparent Cause	Not yet recruiting	2	170	Europe	Serlopitant, VPD-737, Film-coated tablet	Menlo Therapeutics Inc., Menlo Therapeutics Inc.	Refractory Chronic Cough, Chronic cough with no apparent cause, Diseases [C] - Respiratory Tract Diseases [C08]

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
serlopitant (JTS 661) / Vyne Therap
2017-003250-16: A Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Chronic Cough with No Apparent Cause	Not yet recruiting	2	170	Europe	Serlopitant, VPD-737, Film-coated tablet	Menlo Therapeutics Inc., Menlo Therapeutics Inc.	Refractory Chronic Cough, Chronic cough with no apparent cause, Diseases [C] - Respiratory Tract Diseases [C08]